PRO: Vedolizumab should be used before anti-TNFs for moderate to severe IBD
Автор: HMP Education
Загружено: 2015-01-05
Просмотров: 10004
Earn CME for related activities: https://www.naccme.com/gastro
Dedicated to the interests of the entire community of patients with inflammatory bowel disease (IBD), and designed to meet the educational needs of all healthcare professionals who treat and manage patients with IBD, 2014 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical and Research Conference is the foremost event for investigators and healthcare professionals to come together, share their knowledge and experience, and learn about the latest advances and new insights for personalized care of patients with IBD. This webcast was designed to meet the educational needs of all healthcare professionals who treat and manage patients with inflammatory bowel diseases, with a focus on information shared among clinicians and researchers. Participants will gain insight from expert faculty on breakthroughs in cutting-edge research and in advancements in IBD patient care.
In this video, Dr. William J. Sandborn presents: "PRO: Vedolizumab should be used before anti-TNFs for moderate to severe IBD."
© 2015 Imedex, LLC.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
![4 распространённых продукта, которые ухудшают течение язвенного колита [ИЗБЕГАЙТЕ ЭТОГО]: Эксперт...](https://ricktube.ru/thumbnail/sgtHvQRlIC8/mqdefault.jpg)
